FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and pharmaceutics and deals with composition for cancer treatment, which includes compound, presented by structure formula 
(I), and pharmaceutically acceptable crystalline volume filler, where molar ratio of compound (1) to claimed filler constitutes from 1:20 to 1:1, as well as method of its obtaining.
EFFECT: composition has increased activity.
50 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIS(THIOHYDRAZIDE AMIDE)DISALT SYNTHESIS METHOD (VERSIONS) | 2006 |
|
RU2407734C2 |
| PYRROLE CARBOXAMIDES AND PYRROLE THIOCARBOXYLIC ACID AMIDES AND THEIR USING IN AGRICULTURAL CHEMISTRY | 2001 |
|
RU2294925C2 |
| BENDAMUSTINE DERIVATIVES, RELATED COMPOUNDS AND THEIR MEDICAL APPLICATION FOR TREATING CANCER | 2013 |
|
RU2695383C2 |
| THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | 2006 |
|
RU2424238C2 |
| FILM-FORMING COMPOSITION CONTAINING AGENT CAPABLE OF TRAPPING FORMALDEHYDE | 2010 |
|
RU2558104C2 |
| TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE ANTI-ESTROGENIC DRUGS | 2016 |
|
RU2745742C1 |
| FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2125061C1 |
| 3-DEOXYMANNOSEAMINE DERIVATIVE, A METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING INHIBITING EFFECT ON VESSEL AND METASTASIS DEVELOPMENT | 1992 |
|
RU2099333C1 |
| HEAT SENSITIVE RECORDING MATERIAL | 2019 |
|
RU2806321C2 |
| POLYPROPYLENE POLYMER COMPOSITION WITH HIGH RIGIDITY PROPERTIES | 2020 |
|
RU2818186C2 |
